Literature DB >> 2059059

Eosinophil cationic protein in atopic eczema.

T Jakob1, K Hermann, J Ring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2059059     DOI： 10.1007/bf01207241

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  8 in total

1.  Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage.

Authors:  K Fredens; H Dybdahl; R Dahl; U Baandrup
Journal:  APMIS       Date:  1988-08       Impact factor: 3.205

2.  Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis.

Authors:  C A Bruynzeel-Koomen; D F Van Wichen; C J Spry; P Venge; P L Bruynzeel
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

3.  Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis.

Authors:  K M Leiferman; S J Ackerman; H A Sampson; H S Haugen; P Y Venencie; G J Gleich
Journal:  N Engl J Med       Date:  1985-08-01       Impact factor: 91.245

4.  Immune status in atopic eczema: a survey.

Authors:  N A Byrom; D M Timlin
Journal:  Br J Dermatol       Date:  1979-05       Impact factor: 9.302

5.  Radioimmunoassay of human eosinophil cationic protein.

Authors:  P Venge; L E Roxin; I Olsson
Journal:  Br J Haematol       Date:  1977-11       Impact factor: 6.998

6.  Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia.

Authors:  D L Wassom; D A Loegering; G O Solley; S B Moore; R T Schooley; A S Fauci; G J Gleich
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

7.  Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation.

Authors:  C G Peterson; V Skoog; P Venge
Journal:  Immunobiology       Date:  1986-03       Impact factor: 3.144

8.  Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins.

Authors:  L M Zheutlin; S J Ackerman; G J Gleich; L L Thomas
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422
  8 in total
  2 in total

1.  Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.

Authors:  B Wüthrich; M K Kägi; H Joller-Jemelka
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE.

Authors:  O Bäck; A Scheynius; S G Johansson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.